Carriers of pathogenic BRCA1 variants exhibit an estimated cumulative breast cancer risk of approximately 72% by the age of 80, while individuals harboring BRCA2 mutations demonstrate a comparable lifetime risk of around 69% [17]. The gene discussed is BRCA2; the disease is breast cancer.